StockData
Matinas BioPharma Holdings, Inc. logo

Matinas BioPharma Holdings, Inc. (MTNB) stock

MTNBNYSEPharmaceutical PreparationsFiscal year ends December 31
Số liệu tài chính tới Q2 năm tài chính 2026, quý kết thúc ngày Jun 30, 2026Last filing: 10-Q on Nov 16, 2026Score 0/30
$0.91+0.05 (+6.35%)

Close on Nov 18, 2026Market cap $13.37MP/E –Yield –

Matinas BioPharma price to sales ratio

The price-to-sales ratio is market cap divided by revenue over the trailing twelve months.

Matinas BioPharma's price to sales ratio was 301.9× on Jan 31, 2024.

Price to Sales Ratio at the end of each year

PeriodPeriod endValueChange (pts)
2024Jan 31, 2024301.9×−24.4
2023Dec 29, 2023326.3×–

More Matinas BioPharma figures

See a number that looks wrong?